CureDiab Metabolic Research

CureDiab Metabolic Research is a specialized Contract Research Organization (CRO) based in Düsseldorf, Germany, that focuses on clinical trials for metabolic disorders. The company provides expert services for Phase I and II clinical development, with a particular emphasis on diabetes, obesity, and non-alcoholic fatty liver disease. CureDiab is recognized for its proficiency in complex metabolic procedures, including automated glucose clamp techniques and various tissue biopsy methods. It maintains a strong relationship with academic institutions, notably the German Diabetes Center (DDZ), to integrate cutting-edge scientific findings into clinical research. The firm supports global pharmaceutical and biotechnology companies in evaluating the pharmacokinetics and pharmacodynamics of novel metabolic therapies.